NCT07365345 Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients
| NCT ID | NCT07365345 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Air Force Military Medical University, China |
| Condition | Transcatheter Aortic Valve Replacement (TAVR) |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-01-30 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-01-30 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Within 30 minutes before anesthesia, acupoint electrical stimulation at different frequencies were applied at Neiguan, Jian Shi, and Baihui. The changes in blood pressure during the anesthesia induction period were compared between the high-frequency group and the low-frequency group.
Eligibility Criteria
Inclusion Criteria: * The age of the patients is 60 years or older; * Patients who are scheduled to undergo TAVR surgery under general anesthesia; Exclusion Criteria: * Body mass index less than 18 kg/m2 or greater than 30 kg/m2; * Hemodynamic instability (severe arrhythmia, decompensated heart failure); * Hypotension after admission requiring intervention with vasoactive drugs; * Severe liver or kidney dysfunction; * Those who are contraindicated for electrical stimulation, including those with local skin damage, infection, or having implanted electrophysiological devices in the body.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07365345 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Transcatheter Aortic Valve Replacement (TAVR). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07365345 currently recruiting?
Yes, NCT07365345 is actively recruiting participants. Contact the research team at deerlu23@163.com for enrollment information.
Where is the NCT07365345 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT07365345 clinical trial?
NCT07365345 is sponsored by Air Force Military Medical University, China. The trial plans to enroll 150 participants.